Indication

Chronic hepatitis C

Chronic hepatitis C is a persistent, blood-borne hepatic infection caused by the hepatitis C virus (HCV) that fails to clear spontaneously within six months. Read more about Chronic hepatitis C

6 drugs 2 manufacturers

Advertisement

Drugs that treat it

Common Chronic hepatitis C therapies.

Showing 1–6 of 6 drugs

Filter & compare in the drug finder →Opens the drug finder with Chronic hepatitis C preselected.

News & literature

Coming soon

Related codes

Coming soon
Coming soon

About Chronic hepatitis C.

Chronic hepatitis C is a persistent, blood-borne hepatic infection caused by the hepatitis C virus (HCV) that fails to clear spontaneously within six months.

Primarily affecting hepatocytes and the immune system, the condition is characterized pathophysiologically by ongoing immune-mediated inflammation, progressive hepatic fibrosis, and hepatocellular injury.

Clinically, it is defined by detectable circulating HCV RNA and is frequently asymptomatic or clinically indolent for decades until advanced liver disease manifests.

Over time, persistent viremia can lead to severe complications, including cirrhosis, portal hypertension, end-stage liver failure, and hepatocellular carcinoma.

Personalize your experience

Follow Chronic hepatitis C and get updates as they land.

Create a free account

Follow an indication and get alerts when its drugs, labels, or guidelines change

Save any drug on this page to your favorites, synced across devices

AI-curated peer-reviewed research, summarized for your specialty

A morning digest of indication-relevant updates, when you want it